Indraprastha Medical [INDRAMEDCO] vs Dr. Agarwal's Eye [DRAGARWQ] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Indraprastha Medical Corporation Ltd. wins in 11 metrics, Dr. Agarwal's Eye Hospital Ltd. wins in 9 metrics, with 0 ties. Indraprastha Medical Corporation Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Indraprastha Medical Corporation Ltd. | Dr. Agarwal's Eye Hospital Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 20.08 | 34.01 | Indraprastha Medical Corporation Ltd. |
| Price-to-Book Ratio | 5.57 | 7.52 | Indraprastha Medical Corporation Ltd. |
| Debt-to-Equity Ratio | 4.76 | 106.45 | Indraprastha Medical Corporation Ltd. |
| PEG Ratio | -5.81 | 1.81 | Dr. Agarwal's Eye Hospital Ltd. |
| EV/EBITDA | 12.10 | 20.64 | Indraprastha Medical Corporation Ltd. |
| Profit Margin (TTM) | 12.60% | 15.50% | Dr. Agarwal's Eye Hospital Ltd. |
| Operating Margin (TTM) | 13.64% | 19.54% | Dr. Agarwal's Eye Hospital Ltd. |
| EBITDA Margin (TTM) | 13.64% | 19.54% | Dr. Agarwal's Eye Hospital Ltd. |
| Return on Equity | 26.98% | 26.07% | Indraprastha Medical Corporation Ltd. |
| Return on Assets (TTM) | 18.90% | 8.91% | Indraprastha Medical Corporation Ltd. |
| Free Cash Flow (TTM) | $1.20B | $-83.80M | Indraprastha Medical Corporation Ltd. |
| Dividend Yield | 0.95% | 0.11% | Indraprastha Medical Corporation Ltd. |
| 1-Year Return | -13.77% | 14.52% | Dr. Agarwal's Eye Hospital Ltd. |
| Price-to-Sales Ratio (TTM) | 2.53 | 5.39 | Indraprastha Medical Corporation Ltd. |
| Enterprise Value | $32.43B | $26.69B | Indraprastha Medical Corporation Ltd. |
| EV/Revenue Ratio | 2.23 | 5.92 | Indraprastha Medical Corporation Ltd. |
| Gross Profit Margin (TTM) | 37.00% | 78.09% | Dr. Agarwal's Eye Hospital Ltd. |
| Revenue per Share (TTM) | $158 | $952 | Dr. Agarwal's Eye Hospital Ltd. |
| Earnings per Share (Diluted) | $19.94 | $147.68 | Dr. Agarwal's Eye Hospital Ltd. |
| Beta (Stock Volatility) | 0.58 | -0.57 | Dr. Agarwal's Eye Hospital Ltd. |
Indraprastha Medical Corporation Ltd. vs Dr. Agarwal's Eye Hospital Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Indraprastha Medical Corporation Ltd. | 0.17% | 2.46% | -2.81% | 4.08% | -18.78% | -10.90% |
| Dr. Agarwal's Eye Hospital Ltd. | 0.04% | 0.34% | 0.98% | 14.17% | -7.89% | -3.75% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Indraprastha Medical Corporation Ltd. | -13.77% | 314.55% | 315.68% | 619.68% | 949.24% | 1,109.38% |
| Dr. Agarwal's Eye Hospital Ltd. | 14.52% | 234.64% | 1,085.59% | 2,491.74% | 5,250.78% | 17,139.34% |
Performance & Financial Health Analysis: Indraprastha Medical Corporation Ltd. vs Dr. Agarwal's Eye Hospital Ltd.
| Metric | INDRAMEDCO | DRAGARWQ |
|---|---|---|
| Market Information | ||
| Market Cap | ₹37.31B | ₹24.28B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 399,153 | 1,256 |
| 90 Day Avg. Volume | 289,583 | 1,378 |
| Last Close | ₹402.15 | ₹5,129.80 |
| 52 Week Range | ₹342.00 - ₹640.85 | ₹4,142.00 - ₹6,392.00 |
| % from 52W High | -37.25% | -19.75% |
| All-Time High | ₹640.85 (Nov 06, 2025) | ₹7,300.00 (Dec 30, 2024) |
| % from All-Time High | -37.25% | -29.73% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.14% | 0.22% |
| Quarterly Earnings Growth | 0.25% | 0.66% |
| Financial Health | ||
| Profit Margin (TTM) | 0.13% | 0.16% |
| Operating Margin (TTM) | 0.14% | 0.20% |
| Return on Equity (TTM) | 0.27% | 0.26% |
| Debt to Equity (MRQ) | 4.76 | 106.45 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹71.88 | ₹668.22 |
| Cash per Share (MRQ) | ₹50.31 | ₹191.98 |
| Operating Cash Flow (TTM) | ₹1.78B | ₹738.70M |
| Levered Free Cash Flow (TTM) | ₹1.61B | ₹546.50M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.95% | 0.11% |
| Last 12-Month Dividend | ₹4.50 | ₹5.00 |
Valuation & Enterprise Metrics Analysis: Indraprastha Medical Corporation Ltd. vs Dr. Agarwal's Eye Hospital Ltd.
| Metric | INDRAMEDCO (Apr 24, 2026) | DRAGARWQ (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 20.08 | 34.01 |
| Forward P/E | 18.63 | 516.77 |
| PEG Ratio | -5.81 | 1.81 |
| Price to Sales (TTM) | 2.53 | 5.39 |
| Price to Book (MRQ) | 5.57 | 7.52 |
| Market Capitalization | ||
| Market Capitalization | ₹37.31B | ₹24.28B |
| Enterprise Value | ₹32.43B | ₹26.69B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.23 | 5.92 |
| Enterprise to EBITDA | 12.10 | 20.64 |
| Risk & Other Metrics | ||
| Beta | 0.58 | -0.57 |
| Book Value per Share (MRQ) | ₹71.88 | ₹668.22 |
Financial Statements Comparison: Indraprastha Medical Corporation Ltd. vs Dr. Agarwal's Eye Hospital Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | INDRAMEDCO (2025) | DRAGARWQ (2025) |
|---|---|---|
| Revenue/Sales | 13.07B | 3.94B |
| Cost of Goods Sold | 8.53B | 896.20M |
| COGS % of Revenue | 65.3% | 22.8% |
| Gross Profit | 4.54B | 3.04B |
| Gross Margin | 34.7% | 77.2% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 2.10B | 813.30M |
| Operating Margin | 16.1% | 20.6% |
| EBITDA | 2.64B | 1.22B |
| EBITDA Margin | 20.2% | 31.1% |
| Pre-Tax Income | 2.16B | 707.00M |
| Pre-Tax Income % of Revenue | 16.6% | 17.9% |
| Income Tax | 553.30M | 160.50M |
| Income Tax % of Revenue | 4.2% | 4.1% |
| Net Income (Profit) | 1.61B | 546.50M |
| Profit Margin | 12.3% | 13.9% |
Balance Sheet & Liquidity Metrics
| Metric | INDRAMEDCO (2025) | DRAGARWQ (2025) |
|---|---|---|
| Cash & Equivalents | 614.80M | 111.60M |
| Total Current Assets | 4.31B | 559.40M |
| Total Current Assets % of Revenue | 33.0% | 14.2% |
| Total Current Liabilities | 1.79B | 869.80M |
| Total Current Liabilities % of Revenue | 13.7% | 22.1% |
| Long-Term Debt | 305.40M | 3.06B |
| Long-Term Debt % of Revenue | 2.3% | 77.6% |
| Total Shareholders Equity | 5.97B | 2.10B |
| Retained Earnings | 4.75B | 1.99B |
| Retained Earnings % of Revenue | 36.4% | 50.4% |
| Property, Plant & Equipment | 2.60B | 1.37B |
Cash Flow Statement Comparison
| Metric | INDRAMEDCO (2025) | DRAGARWQ (2025) |
|---|---|---|
| Operating Cash Flow | 1.78B | 738.70M |
| Operating Cash Flow % of Revenue | 13.6% | 18.8% |
| Capital Expenditures | -363.30M | 4.10M |
| Free Cash Flow | 1.20B | -83.80M |
| FCF Margin | 9.2% | -2.1% |
| Debt Repayment | N/A | -111.30M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | INDRAMEDCO | DRAGARWQ |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 91.67M | 4.83M |
| Float Shares | 41.01M | 1.08M |
| % Held by Insiders | 55.41% | 77.59% |
| % Held by Institutions | 0.57% | 3.57% |
| % Held by Public | 44.02% | 18.84% |
Dividend Analysis & Yield Comparison: Indraprastha Medical Corporation Ltd. vs Dr. Agarwal's Eye Hospital Ltd.
| Metric | INDRAMEDCO | DRAGARWQ |
|---|---|---|
| Last 12-Month Dividend | ₹4.50 | ₹5.00 |
| Last 12-Month Dividend Yield | 0.95% | 0.11% |
| 3-Year Avg Annual Dividend | ₹4.00 | ₹4.50 |
| 3-Year Avg Dividend Yield | 1.26% | 0.12% |
| 3-Year Total Dividends | ₹12.00 | ₹13.50 |
| Ex-Dividend Date | Sep 18, 2025 | Nov 08, 2024 |